SOX9 promotes stemness in the CAL27 cell line of tongue squamous cell carcinoma
© 2024 John Wiley & Sons Ltd..
Tongue squamous cell carcinoma (TSCC) is a prevalent form of oral malignancy, with increasing incidence. Unfortunately, the 5-year survival rate for patients has not exceeded 50%. Studies have shown that sex-determining region Y box 9 (SOX9) correlates with malignancy and tumor stemness in a variety of tumors. To investigate the role of SOX9 in TSCC stemness, we analyzed its influence on various aspects of tumor biology, including cell proliferation, migration, invasion, sphere and clone formation, and drug resistance in TSCC. Our data suggest a close association between SOX9 expression and both the stemness phenotype and drug resistance in TSCC. Immunohistochemical experiments revealed a progressive increase of SOX9 expression in normal oral mucosa, paracancerous tissues, and tongue squamous carcinoma tissues. Furthermore, the expression of SOX9 was closely linked to the TNM stage, but not to lymph node metastasis or tumor diameter. SOX9 is a crucial gene in TSCC responsible for promoting the stemness function of cancer stem cells. Developing drugs that target SOX9 is extremely important in clinical settings.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Cell biochemistry and function - 42(2024), 3 vom: 03. Apr., Seite e4000 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sheng, Nanning [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer stem cells |
|---|
| Anmerkungen: |
Date Completed 04.04.2024 Date Revised 04.04.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1002/cbf.4000 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370558375 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370558375 | ||
| 003 | DE-627 | ||
| 005 | 20240404235457.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240404s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cbf.4000 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1365.xml |
| 035 | |a (DE-627)NLM370558375 | ||
| 035 | |a (NLM)38566395 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sheng, Nanning |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SOX9 promotes stemness in the CAL27 cell line of tongue squamous cell carcinoma |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.04.2024 | ||
| 500 | |a Date Revised 04.04.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 John Wiley & Sons Ltd. | ||
| 520 | |a Tongue squamous cell carcinoma (TSCC) is a prevalent form of oral malignancy, with increasing incidence. Unfortunately, the 5-year survival rate for patients has not exceeded 50%. Studies have shown that sex-determining region Y box 9 (SOX9) correlates with malignancy and tumor stemness in a variety of tumors. To investigate the role of SOX9 in TSCC stemness, we analyzed its influence on various aspects of tumor biology, including cell proliferation, migration, invasion, sphere and clone formation, and drug resistance in TSCC. Our data suggest a close association between SOX9 expression and both the stemness phenotype and drug resistance in TSCC. Immunohistochemical experiments revealed a progressive increase of SOX9 expression in normal oral mucosa, paracancerous tissues, and tongue squamous carcinoma tissues. Furthermore, the expression of SOX9 was closely linked to the TNM stage, but not to lymph node metastasis or tumor diameter. SOX9 is a crucial gene in TSCC responsible for promoting the stemness function of cancer stem cells. Developing drugs that target SOX9 is extremely important in clinical settings | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a SOX9 | |
| 650 | 4 | |a cancer stem cells | |
| 650 | 4 | |a chemoresistance | |
| 650 | 4 | |a cisplatin | |
| 650 | 4 | |a fluorouracil | |
| 650 | 4 | |a paclitaxel | |
| 650 | 4 | |a tongue squamous cell carcinoma | |
| 650 | 7 | |a SOX9 protein, human |2 NLM | |
| 650 | 7 | |a SOX9 Transcription Factor |2 NLM | |
| 700 | 1 | |a Fu, Rong |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Chuhuan |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Fan, Yawei |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Jue |e verfasserin |4 aut | |
| 700 | 1 | |a Nan, Xinrong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell biochemistry and function |d 1984 |g 42(2024), 3 vom: 03. Apr., Seite e4000 |w (DE-627)NLM012967254 |x 1099-0844 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2024 |g number:3 |g day:03 |g month:04 |g pages:e4000 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/cbf.4000 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2024 |e 3 |b 03 |c 04 |h e4000 | ||